FDA OKs Xeris Pharma low blood sugar pen

The company announced positive results from two of its Phase 3 clinical studies on the investigational ready-to-use, room-temperature stable liquid glucagon rescue pen at the American Diabetes Association ’s 78th Scientific Sessions
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news